Precision Biosciences (DTIL) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$44.9 million.
- Precision Biosciences' Enterprise Value rose 5566.29% to -$44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.9 million, marking a year-over-year increase of 5566.29%. This contributed to the annual value of -$86.3 million for FY2024, which is 2602.55% up from last year.
- Per Precision Biosciences' latest filing, its Enterprise Value stood at -$44.9 million for Q3 2025, which was up 5566.29% from -$62.2 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Enterprise Value ranged from a high of -$44.9 million in Q3 2025 and a low of -$212.1 million during Q3 2022
- Over the past 5 years, Precision Biosciences' median Enterprise Value value was -$137.8 million (recorded in 2024), while the average stood at -$133.8 million.
- Per our database at Business Quant, Precision Biosciences' Enterprise Value crashed by 5998.46% in 2021 and then skyrocketed by 5566.29% in 2025.
- Quarter analysis of 5 years shows Precision Biosciences' Enterprise Value stood at -$143.7 million in 2021, then plummeted by 31.96% to -$189.6 million in 2022, then surged by 38.45% to -$116.7 million in 2023, then grew by 26.03% to -$86.3 million in 2024, then soared by 48.01% to -$44.9 million in 2025.
- Its Enterprise Value stands at -$44.9 million for Q3 2025, versus -$62.2 million for Q2 2025 and -$77.2 million for Q1 2025.